A compendiu m of carcinogenesi s bioassay results organized by target organ is presented for 738 chemicals that are carcinogenic in chronic-exposure , long-term bioassays in at least 1 species. This compendium is based primarily on experiments in rats or mice; results in hamsters, monkeys, and dogs are also reported. The compendium can be used to identify chemicals that induce tumors at particular sites and to determine whether target sites are the same for chemicals positive in more than 1 species. The source of information is the Carcinogeni c Potency Database (CPDB), which includes results of 6073 experiments on 1458 chemicals (positive or negative for carcinogenicity) that have been reported in Technical Reports of the National Cancer Institute/National Toxicology Program or in papers in the general published literature. The published CPDB includes detailed analyses of each test and citations. The CPDB is publicly available in several formats (http://potency.berkeley.edu). Chemical carcinogens are reported for 35 different target organs in rats or mice. Target organs in humans are also summarized for 82 agents that have been evaluated as human carcinogens at a particular target site by the International Agency for Research on Cancer (IARC). Comparisons are provided of target organs for mutagens versus nonmutagens and rats versus mice.
INTRODUCTION
For many research issues in carcinogenesis, it is valuable to have quick access to a list of chemicals that have been found in chronic bioassays to induce tumors at each target site in various species. Researchers interested in carcinogenesis in a particular target organ, for example, or epidemiologists interested in a particular cancer in humans, can use such results to compare species or seek clues in animal models. Comparison of target sites in several species is possible for work on interspecies extrapolation. Investigations of chemical structure or mechanism of carcinogenesis at a speci c target site can identify chemicals that induce tumors in that organ. This paper presents a compendium of results of chronic, long-term cancer tests that is organized by the target organ of carcinogenesis (Table 1) . Results are presented for 738 chemicals that have been evaluated by the published author of experimental data as carcinogenic in at least one experiment in the Carcinogenic Potency Database (CPDB) (2, 3, 6) , http://potency.berkeley.edu/database.html. Results are organized by each of 35 target sites and within each site by the chemicals that induce tumors in each species. The compendium includes results of chronic bioassays in rats, mice, hamsters, monkeys, and dogs. Comparative toxicological analyses are facilitated by indicating whether a chemical that is positive at a given site in the rat has been tested in the mouse, whether results are also positive in the mouse, and whether the target organs are the same in the 2 species. By cross-referencing a chemical of interest to the published plots of the CPDB (2, 3, 6) , details of each experiment can be obtained, including the number of experiments and strains tested as well as the following details on each experiment: citation of the original published paper, strain and sex of test animal, route of chemical administration, dose rate, tumor types, tumor incidence, the tumorigenic potency (TD 50 ), statistical signi cance, and author's opinion. Target organs in humans are also summarized for 82 agents that have been evaluated as human carcinogens at a particular target site by the International Agency for Research on Cancer (IARC) (10, 15, 16) . Comparisons of target organs for mutagens versus nonmutagens, and for rats versus mice are also provided.
METHODS
The CPDB (2, 3, 6) , a systematic and unifying analysis of chronic, long-term animal cancer tests, is the source of 639 0192-6233/01$3.00 $0.00 results included in the compendium ( Table 1 ). The CPDB includes 1,381 papers published in the general literature through 1996 and 430 Technical Reports of the National Cancer Institute/National Toxicology Program (NCI/NTP) published through 1998. Results are reported for 6,073 experiments on 1,458 chemicals, of which 738 induce tumors in 1 or more experiments.
A word of caution is necessary about the limitations of the CPDB. Only long-term experiments meeting a set of criteria designed to measure tumorigenic dose-rate (TD 50 ) are included; therefore, the CPDB does not cover all cancer tests. Additionally, for the identi cation of target sites for the compendium, we do not personally evaluate whether a compound induced tumors at a given site; rather, the opinion of the published author is used. For published opinions that are not clear, even after personal communication with the published author, the site is not considered a target and is not reported in the compendium.
Results of all NCI/NTP Technical Reports are included in the CPDB except a few, for which no whole body exposure in mg/kg/day could be calculated because the test agent was a particulate or the route of administration was dermal (12, 13) [http://ntp-server.niehs.nih.gov/]. In the compendium, a site is classi ed as a target in an NCI/NTP bioassay if the evaluation in the Technical Report was "carcinogenic," "clear," or "some" evidence of carcinogenic activity. Sites that were evaluated as "equivocal" are not included (9) .
In the general literature, experimental designs as well as the authors' choice of information to report are quite diverse, and bioassays have been included only if they meet all of the following conditions:
1. Animals on test were mammals. 2. Administration was begun early in life (100 days of age or less for rats, mice, and hamsters). 3. Route of administration was diet, water, gavage, inhalation, intravenous or intraperitoneal injection (ie, where the whole body was more likely to have been exposed rather than only a speci c site, as with subcutaneous injection or skin painting). 4. Test agent was administered alone, rather than in combination with other chemicals. 5. Exposure was chronic, with not more than 7 days between administrations. 6. Duration of exposure was at least one fourth the standard life span for that species. For rodents the standard life span is 2 years. 7. Duration of experiment was at least half the standard life span for that species. 8. Research design included a concurrent control group. 9. Research design included at least 5 animals per group. 10. Surgical intervention was not performed. 11. Pathology data were reported for the number of animals with tumors rather than the total number of tumors. 12. Results reported were original data, rather than secondary analyses of experiments already reported by other authors.
More details on inclusion criteria can be found in Gold and coworkers (6) and http://potency.berkeley.edu/text/ methods.html.
Because we have adhered strictly to the standard inclusion criteria, bioassays of particulate or brous matters are not in the compendium, eg, asbestos, cigarette smoke, and dusts. There are no studies using a single administration of the test agent, no experiments by skin painting, subcutaneous injection, or in utero exposure, and no cocarcinogenesis experiments. For a series of NCI long-term studies in monkeys, some of the inclusion rules have been relaxed; details are reported in Appendix 1 of Gold et al, 1999 (2) .
There is great diversity in results for different chemicals in the CPDB, eg, in the number of times a chemical has been tested: among the 1,148 chemicals tested in rats, 25% have only 1 test in the CPDB and 50% have 2 tests; however, 25 chemicals have 10 or more tests. For the 938 chemicals tested in mice, the parallel numbers are 11% with 1 test, 57% with 2 tests, and 15 chemicals with more than 10 tests. Of the 738 carcinogens reported here, 54% (397/738) have been tested in more than 1 species. In the compendium (Table 1) , a target site is identi ed by a positive result in any one experiment in the species; thus, different target sites may be identi ed from the same or different experiments. Chemicals that are tested more often have a greater chance of nding multiple target sites. Results on chemicals that have not been evaluated as carcinogenic are ignored in the target organ compendium (Table 1) ; however, detailed results of those experiments are reported in the plot of the CPDB (2, 3, 6) ; http://potency.berkeley.edu/.
Guide to the Compendium of Target Organs for 738
Carcinogens Table 1 reports results on 738 chemicals in the CPDB that induce tumors in at least 1 of 35 target organs in rats, mice, hamsters, monkeys, or dogs. The table is organized alphabetically by target site and within each site, by species and chemical. Our previously unpublished analyses of experimental results that will be published in a forthcoming plot of the CPDB are included (3) .
To facilitate use of the compendium, the features are described below using the example of adrenal gland, which is the rst of 35 target sites in Table 1 . Under adrenal gland, 1 chemical is listed in hamsters, 8 in mice, and 16 in rats. If a chemical name is followed by a superscript (either y or z ), this indicates that the CPDB includes test results in both rats and mice, for example, under adrenal gland in rats 2-mercaptobenzothiazole but not isomazole, has a superscript. Because isomazole has no superscript, it only has tests in the CPDB in the species reported, in this case rats. The superscript y for 2-mercaptobenzothiazole, indicates that the chemical has been tested in both rats and mice but induced tumors only in the reported species, in this case rats. The superscript z for 1,2-dibromo-3-chloropropane (DBCP) indicates that DBCP is carcinogenic at some target site in both rats and mice. Although the superscript z does not indicate whether DBCP induced tumors at the same target site in both rats and mice, this can easily be determined by looking at mice under adrenal gland for the chemical name DBCP. Because it is not there, DBCP induced tumors in mice only at sites other than the adrenal gland. In contrast, pentachloroanisole z induced adrenal tumors in both species, beacuse it is listed under that site for both species. By comparing the chemicals with superscripts listed under each -Ethyl-O,N,N-azoxyethane; N-Methyl-N - 
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(Continued on next page) 643 N-Nitroso-bis- (4,4,4-tri uoro-N-butyl) amine; N-Nitroso-N-methyl-N-dodecylamine; N-Nitroso-N-methyl-N-tetradecylamine; N-Nitroso-N-methyldecylamine; N-Nitroso-N-methylurea z ; N-Nitrosobis (2-hydroxypropyl) amine; N-Nitrosobis-2,3-dihydroxypropylamine;
(2-oxopropyl)amine; Nitrosodibutylamine z ; N-Nitrosodimethylamine z ; N-Nitrosoephedrine;
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Nitroso-1,2,3,6-tetrahydropyridine; N-Nitrosobis (2-oxopropyl) amine; N-Nitrosodiethanolamine; N-Nitrosodiethylamine; N-Nitrosodimethylamine z ; N-Nitrosomethyl- (2-tosyloxyethyl) Oral cavity includes tissues of the mouth, oropharynx, pharynx, and larynx. A chemical is listed under each organ evaluated as positive in an experiment in that species by at least 1 author. Therefore, a chemical may be listed under several target organs and every chemical listed in the table is positive in at least 1 species. In order to compare results in rats and mice, symbols follow chemicals tested in both species: a z indicates that the chemical is positive at some site in both species, and a y indicates that it was tested in both but positive in only 1. a N the number of chemicals with at least 1 positive test at that site in that species. Because many chemicals induce tumors at more than 1 site in a given species, many chemicals appear more than once in the table.
species, the reader can determine that pentachloroanisole is the only chemical that induced adrenal tumors in both rats and mice. The superscripts y and z apply only to results in rats and mice; for example, hamsters are reported under adrenal gland for urethane with the symbol z , indicating that urethane was positive at some site in rats and mice; however, the superscript does not indicate anything about hamsters.
RESULTS IN RATS AND MICE For rats and mice, Table 2 summarizes the proportion of carcinogens that are positive at each target organ, based on the results presented in the compendium (Table 1 ). In Table 2 , the target sites are ordered by how frequently the site is positive in either rats or mice. A summary of the compendium is given under the headings "All Chemicals" for rats (N 526) and mice (N 412). Additionally, for the subset of carcinogens that have been tested in Salmonella (N 459), results in each species are reported separately for mutagens and nonmutagens. A chemical is classi ed as mutagenic in the Salmonella assay if it was evaluated as either "mutagenic" or "weakly mutagenic" by Zeiger (17) or as "positive" by the Gene-Tox Program (11, 14) and A. Auletta (personal communication April 1990) . This summary table permits simple comparisons between species and between mutagens and nonmutagens. In the CPDB, 722 chemicals are carcinogeni c in rats and/or mice, but mutagenicity in Salmonella is known for only 459 of them. The column "All chemicals" reports results for all carcinogens in each species, whether mutagenicity results are available or not. b % Percentage of rat carcinogen s or mouse carcinogen s that induce tumors at the given site. Many chemicals induce tumors at more than 1 site, and these are counted at each relevant target site. Therefore, many chemicals are counted more than once, and percentages cannot be added. For example, of 206 chemicals that induce liver tumors in rats, 126 (61%) are positive in at least one other site in rats.
All Carcinogens in Rats or Mice
Among rodent carcinogens, it is common for a chemical to induce tumors at more than one site in a species, and this is re ected in Table 2 where many chemicals are counted under more than one site. Multiple-site carcinogenesis is more common in rats (52%, 247/471) than mice (45%, 171/384), with 3 or more target sites also more common in rats (31%, 148/471 compared to 19%, 72/384 in mice). Fewer chemicals are included in the multiple-site analysis than the totals in Table 2 because multiple-site carcinogenesis cannot be measured for experiments that restrict histopathological examination or report data for only a couple of selected tissues. Results are similar when experiments with restricted analyses are included.
The liver is the most frequent target site in mice (56%) and rats (39%) ( Table 2 ). The second most common sites are the mouse lung (28%) and the rat mammary gland (19%). Among the 44 carcinogens in hamsters, the most frequent sites are stomach and liver. For the 11 carcinogens in monkeys, liver is the most frequent target site.
Despite the wide variety of target organs in rats and mice (Tables 1 and 2), due to (a) the frequency of multiple-site carcinogenesis and (b) the frequency of tumorigenesis in a few common sites like liver, most chemical carcinogens in rats and mice can be identi ed by just the 8 most common IARC has evaluated an additional 5 agents as having an overall evaluation, "carcinogeni c to humans " but all 5 lack an IARC evaluation of "suf cient evidence" of carcinogenicit y to humans: a -particle-emitting radionuclides , internally deposited; b -particle-emitting radionuclides , internally deposited; ethylene oxide; neutron radiation; and TCDD.
IARC has evaluated the evidence of carcinogenicit y in animals as "suf cient" for these 40 human carcinogens . a Tissues are reported in Table 1 for rodent experiments in the CPDB. b Tissues reported in Table 1 for monkey experiments in the CPDB. c Experiments are reported in the CPDB, but none are positive. d For 5 chemicals, there are positive tests with target sites in the CPDB; however, for the agent or exposure circumstance evaluated by IARC as "carcinogeni c to humans" there are no tests in the CPDB: auramine-O, estradiol, ethyl alcohol, phenacetin, and rosaniline (Magenta I).
e For 6 human carcinogen s IARC considers the evidence of carcinogenicit y in experimenta l animals as "suf cient" for some chemical constituent, but the group or exposure circumstance is not evaluated as "suf cient" in animals: auramine manufacture ; estrogens, steroidal and nonsteroidal ; estrogens, postmenopausal therapy; magenta manufacture ; and oral contraceptives , combined. sites: liver, lung, mammary gland, stomach, vascular system, kidney, hematopoietic system, and urinary bladder (7) . Overall, 92% (354/384) of mouse carcinogens and 82% (388/471) of rat carcinogens are positive in at least one of these 8 sites.
Mutagenicity and Target Site
Mutagens compared to nonmutagens are: (a) more likely to be carcinogenic; (b) more likely to induce tumors at multiple target sites; and (c) more likely to be carcinogenic in 2 species (4, 5, 8) .
Since tissue distribution and pharmacokinetics would not be expected to differ systematically between mutagens and nonmutagens, one would not expect systematic differences in the particular organs in which tumors are induced (8) . Table 2 do not support the idea that mutagens and nonmutagens induce tumors in different target organs. Liver is the most common site for both mutagens and nonmutagens; most organs are target sites for both mutagens and nonmutagens, and both mutagens and nonmutagens induce tumors in a wide variety of sites. Moreover, the same sites tend to be the most common sites for both: at least 81% of either mutagens or nonmutagens are positive in each species in at least one of the 8 most frequent target sites. We earlier compared results for mutagens and nonmutagens in speci c tissues (18).
Results in

Target Organs of Human Carcinogens
To complement the compendium of target organs in carcinogenesis bioassays (Table 1) , Table 3 reports the target organs of carcinogenicity in humans for 82 agents that the International Agency for Research in Cancer (IARC) evaluates as human carcinogens at a particular target site (10, 15, 16) , http://www.iarc.fr/. In addition to individual chemicals such as those reported in Table 1 for bioassays, the agents that IARC evaluates as human carcinogens include industrial processes, therapeutic combinations, infectious agents, ionizing radiation, and mixtures such as tobacco smoke.
In Table 3 , footnotes indicate which chemicals are included in the CPDB among the 82 IARC human carcinogens with human target sites. The reader can compare positivity and target sites in humans, rodents and monkeys for human carcinogens by searching for a chemical name in our table "Results by Chemical" on the Web (http://potency.berkeley.edu/chemicalsummary.html) or in our plot of the CPDB (http://potency.berkeley.edu/ database.html).
Among the 82 human carcinogens with target sites, IARC considers 52 to have been adequately tested in experimental animals. Agents that have not been tested adequately are mostly exposure circumstances like the workplace, or infectious agents. Of the 52 that have been tested in animals, IARC evaluates 12 as having "limited evidence" in animals and 40 as "suf cient evidence." (The 40 include 6 agents for which a chemical constituent has "suf cient evidence" even though the group or exposure circumstance that is a human carcinogen, does not, e.g., auramine-O for auramine manufacture.) The 40 agents with "suf cient evidence" in animals are indicated in Table 3 by a " ". Thus, evidence of carcinogenicity is "suf cient" in experimental animals for only 40/82 (49%) of human carcinogens.
Ultimately, for purposes of investigating interspecies extrapolation or the practice of risk assessment to humans from bioassay data, one wants to know whether the large number (many hundreds) of chemicals that have been shown to be carcinogenic in experimental animals would also be carcinogenic in humans. This question cannot be answered by reversing the question, that is, by asking whether the small number of chemicals that are carcinogenic to humans are also carcinogenic in rodent bioassays. The reason for this is that even if most human carcinogens were carcinogenic to experimental animals, the converse does not necessarily follow, as can be demonstrated by a simple probabilistic argument (1) .
